White House releases drug policy priorities
The Biden-Harris administration yesterday sent Congress its first-year drug policy priorities, as required by each new administration.
They call for expanding access to evidence-based treatment; advancing racial equity in drug policy; enhancing evidence-based efforts to reduce harm; supporting evidence-based efforts to prevent youth substance use; reducing the supply of illicit substances; removing barriers to employment for people in recovery and expanding the addiction workforce; and expanding access to recovery support services.
Related News Articles
Headline
The AHA Aug. 28 shared concerns with the Centers for Medicare & Medicaid Services regarding the calendar year 2027 hospital outpatient prospective payment…
Headline
The AHA provided comments to the Centers for Medicare & Medicaid Services Aug. 28 on its calendar year 2027 home health prospective payment system proposed…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The Department of Homeland Security today released a proposed rule to establish a new $103,265 filing fee for H-1B visa petitions that are subject to statutory…
Headline
President Trump announced Aug. 19 that he has nominated Heidi Overton to serve as the next commissioner of the Food and Drug Administration. Overton currently…
Headline
The 5th U.S. Circuit Court of Appeals Aug. 11 ruled to vacate certain regulations implementing how the No Surprises Act qualifying payment amount is calculated…